Literature DB >> 28554843

NF-κB signaling and cell-fate decision induced by a fast-dissociating tumor necrosis factor mutant.

Xiaoling Zhang1, Ning Yin1, Annan Guo2, Qi Zhang3, Yalei Zhang2, Youjun Xu1, Hongbo Liu2, Bo Tang1, Luhua Lai4.   

Abstract

Tumor necrosis factor (TNF) is a pluripotent inflammatory cytokine that can induce both the pro-survival nuclear factor kappa B (NF-κB) pathway and the pro-apoptotic caspase pathway. Selectively activating only one of the two pathways remains challenging. We used TNF mutants with different receptor binding kinetics to study their effects on NF-κB signaling dynamics and cell apoptosis. A TNF mutant, R1antTNF, which binds to TNFR1 with increased association and dissociation rates, induced NF-κB signaling with shorter response time and first peak duration. The short nuclear stay of NF-κB led to biased activation of downstream genes, favoring the fast response ones. At the same time, R1antTNF retains pro-apoptotic activity. At 10 ng/ml, R1antTNF selectively activated the pro-apoptotic pathway rather than the pro-survival NF-κB pathway. Our study provides a new example for the emerging evidence that ligand-receptor binding kinetics play a key role in the selective activation of downstream pathways, which deserves more attention in future drug discovery and disease studies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Biased activation; Gene expression; NF-κB signaling dynamics; Receptor-ligand binding kinetics; TNF

Mesh:

Substances:

Year:  2017        PMID: 28554843     DOI: 10.1016/j.bbrc.2017.05.149

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  A novel allosteric inhibitor that prevents IKKβ activation.

Authors:  Hongbo Liu; Hao Liang; Hu Meng; Xiaobing Deng; Xiaoling Zhang; Luhua Lai
Journal:  Medchemcomm       Date:  2018-01-09       Impact factor: 3.597

Review 2.  Selective Targeting of TNF Receptors as a Novel Therapeutic Approach.

Authors:  Roman Fischer; Roland E Kontermann; Klaus Pfizenmaier
Journal:  Front Cell Dev Biol       Date:  2020-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.